Epidemiology, longitudinal treatment patterns and outcomes of chronic lymphocytic leukemia in Israel

References

• Rai KR, Stilgenbauer S, Aster JC. Clinical features and diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma. In: Connor RF, editor. UpToDate; 2019. Available from: https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma.
   Google Scholar
• Cramer P, Hallek M, Eichhorst B. State-of-the-art treatment and novel agents in chronic lymphocytic leukemia. Oncol Res Treat. 2016;39(1–2):25–32.
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S, Eichhorst B, Schetelig J, et al. Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. Lancet Oncol. 2016;17(6):768–778.
   PubMed Web of Science ®Google Scholar
• Cohen R, Damari N. Membership in health funds in 2017. Jerusalem, Israel: Israel National Insurance Institute; 2018.
   Google Scholar
• Weil C, Gelerstein S, Sharman Moser S, et al. Real-world epidemiology, treatment patterns and survival of multiple myeloma patients in a large nationwide health plan. Leuk Res. 2019;85:106219.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87(12):4990–4997.
   Google Scholar
• Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111(12):5446–5456.
   PubMed Web of Science ®Google Scholar
• Call TG, Norman AD, Hanson CA, et al. Incidence of chronic lymphocytic leukemia and high‐count monoclonal B‐cell lymphocytosis using the 2008 guidelines. Cancer. 2014;120(13):2000–2005.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Kay NE, Jenkins G, et al. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood. 2009;113(18):4188–4196.
   PubMed Web of Science ®Google Scholar
• Mato A, Jahnke J, Li P, et al. Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era. Haematologica. 2018;103(10):e462–e465.
   PubMed Web of Science ®Google Scholar
• Israel Central Bureau of Statistics. Characterization and classification of geographic units by the socio-economic level of the population 2008. Publication No. 1530. Jerusalem, Israel 2013.
   Google Scholar
• BMI Classification [Internet]. 2006. [cited 2014]. Available from: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.
   Google Scholar
• Chodick G, Heymann AD, Shalev V, et al. The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol. 2002;18(12):1143–1146.
   Web of Science ®Google Scholar
• Shalev V, Chodick G, Goren I, et al. The use of an automated patient registry to manage and monitor cardiovascular conditions and related outcomes in a large health organization. Int J Cardiol. 2011;152(3):345–349.
   PubMed Web of Science ®Google Scholar
• Coresh J, Turin TC, Matsushita K, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518–2531.
   PubMed Web of Science ®Google Scholar
• Weitzman D, Chodick G, Shalev V, et al. Prevalence and factors associated with resistant hypertension in a large health maintenance organization in Israel. Hypertension. 2014;64(3):501–507.
   PubMed Web of Science ®Google Scholar
• Israel Center for Disease Control. Israel national cancer registry. Jerusalem, Israel: Ministry of Health; 2018.
   Google Scholar
• Ra Deyo DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619.
   PubMed Web of Science ®Google Scholar
• Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age standardization of rates: a new WHO standard. Vol. 31. Geneva: World Health Organization; 2001.
   Google Scholar
• National Cancer Institute. 2013. World (WHO 2000–2025) Standard – adjustment for SEER*Stat Standard; [cited 2017]. Available from: https://seer.cancer.gov/stdpopulations/world.who.html
   Google Scholar
• Miranda-Filho A, Pineros M, Ferlay J, et al. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol. 2018;5(1):e14–e24.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute S, Epidemiology, and End Results Program. Cancer Stat Facts: leukemia – chronic lymphocytic leukemia. 2019. Available from: https://seer.cancer.gov/statfacts/html/clyl.html
   Google Scholar
• Larsson K, Mattsson M, Ebrahim F, et al. Prevalence and incidence of cardiovascular disease in chronic lymphocytic leukemia: a nation-wide population-based study: PF379. Hemasphere. 2019;3(S1):141–142.
   Google Scholar
• Weide R, Feiten S, Chakupurakal G, et al. Survival improvement of patients with chronic lymphocytic leukemia (CLL) in routine care 1995–2017. Leuk Lymphoma. 2019;61(3):557–566.
   PubMedGoogle Scholar
• Schenkel B, Rider A, Macomson B, et al. Real-world treatment patterns and characteristics in patients with chronic lymphocytic leukemia. J Clin Oncol. 2017;35(8_suppl):65–65.
   Web of Science ®Google Scholar
• Mato A, Nabhan C, Kay NE, et al. Real-world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres. Br J Haematol. 2016;175(5):892–903.
   PubMed Web of Science ®Google Scholar
• Sylvan SE, Asklid A, Johansson H, et al. First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013. Haematologica. 2019;104(4):797–804.
   PubMed Web of Science ®Google Scholar
• Richardson PG, San Miguel JF, Moreau P, et al. Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting. Blood Cancer J. 2018;8(11):1–12.
   PubMedGoogle Scholar
• Eichhorst B, Fink AM, Bahlo J, et al. First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial. Lancet Oncol. 2016;17(7):928–942.
   PubMed Web of Science ®Google Scholar
• Goede V, Fischer K, Hallek M. Chemoimmunotherapy for chronic lymphocytic leukemia. Author reply. N Engl J Med. 2014;370(24):2348–2349.
   PubMed Web of Science ®Google Scholar
• Kristinsson SY, Dickman PW, Wilson WH, et al. Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973–2003 in Sweden. Haematologica. 2009;94(9):1259–1265.
   PubMed Web of Science ®Google Scholar
• Wu S-J, Chiang C-J, Lin C-T, et al. Improving but inferior survival in patients with chronic lymphocytic leukemia in Taiwan: a population-based study, 1990-2004. PLOS One. 2013;8(4):e62930.
   PubMed Web of Science ®Google Scholar
• Abrisqueta P, Pereira A, Rozman C, et al. Improving survival in patients with chronic lymphocytic leukemia (1980–2008): the Hospital Clinic of Barcelona experience. Blood. 2009;114(10):2044–2050.
   PubMed Web of Science ®Google Scholar
• Lenartova A, Johannesen TB, Tjønnfjord GE. National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953–2012: a systematic analysis of population‐based data. Cancer Med. 2016;5(12):3588–3595.
   PubMed Web of Science ®Google Scholar
• Marti GE, Rawstron AC, Ghia P, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol. 2005;130(3):325–332.
   PubMed Web of Science ®Google Scholar
• Seymour EK, Ruterbusch JJ, Beebe-Dimmer JL, et al. Real-world testing and treatment patterns in chronic lymphocytic leukemia: a SEER patterns of care analysis. Cancer. 2019;125(1):135–143.
   PubMed Web of Science ®Google Scholar